Impact of FGFR3 genomic aberrations in patients with metastatic urothelial carcinoma treated with first line platinum-based chemotherapy
| Autor: | Juana M. Rodríguez, Cristina Suarez, N. Díaz, Joan Morote, Marcela Hernández, I. De Torres, Xavier Maldonado, Claudia Valverde, M. Altabas, C. Fernandez, J. Carles, R. Morales Barrera, Marta Gonzalez, E. Serra, S. Gutierrez, Carlos Gasanz Serrano, Fernando Lozano, S. Roche, Richard Mast, M.E. Semidey, Joaquin Mateo |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: |
Chemotherapy
Metastatic Urothelial Carcinoma business.industry Urology medicine.medical_treatment First line chemistry.chemical_element lcsh:Diseases of the genitourinary system. Urology lcsh:RC870-923 lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens lcsh:RC254-282 chemistry medicine Cancer research In patient business Platinum |
| Zdroj: | European Urology Open Science, Vol 19, Iss, Pp e1585-(2020) |
| ISSN: | 2666-1683 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|